ABS — Arctic Bioscience AS Cashflow Statement
0.000.00%
Last trade - 00:00- NOK89.49m
- NOK149.68m
- NOK40.10m
Annual cashflow statement for Arctic Bioscience AS, fiscal year end - December 31st, millions except per share.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ||
| Standards: | — | — | NAS | NAS | NAS |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | — | -45.5 | -47.9 | -41 |
| Depreciation | |||||
| Non-Cash Items | — | — | 0 | -0.013 | -0.005 |
| Unusual Items | |||||
| Changes in Working Capital | — | — | 9.76 | -2.56 | 13.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | — | -30.4 | -45.4 | -22.7 |
| Capital Expenditures | — | — | -34.7 | -50.8 | -22.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 2.23 | 0.184 | 0.05 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -32.5 | -50.6 | -22.7 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | -1.71 | 19.7 | 43.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | — | -64.5 | -76.3 | -1.99 |